BioCorRx Inc logo

BICX - BioCorRx Inc Share Price

$2.4 0.0  1.3%

Last Trade - 2:30pm

Sector
Healthcare
Size
Micro Cap
Market Cap £9.21m
Enterprise Value £8.77m
Revenue £117k
Position in Universe 6158th / 6642
Bullish
Bearish
Unlock BICX Revenue
Momentum
Relative Strength (%)
1m +56.1%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -24.0%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
1.17 0.92 0.70 0.66 0.38 0.24 130.5 188.4 -27.1%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the nine months ended 30 September 2020,Biocorrx Inc revenues decreased 44% to $100K. Net lossdecreased 47% to $2.6M. Revenues reflect a decrease indemand for the Company's products and services due tounfavorable market conditions. Lower net loss reflectsGrant income increase from $582K to $3.5M (income), Selling, general and administrative decrease of 33% to $2.4M(expense), Interest expense.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

BICX Revenue Unlock BICX Revenue

Net Income

BICX Net Income Unlock BICX Revenue

Normalised EPS

BICX Normalised EPS Unlock BICX Revenue

PE Ratio Range

BICX PE Ratio Range Unlock BICX Revenue

Dividend Yield Range

BICX Dividend Yield Range Unlock BICX Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
BICX EPS Forecasts Unlock BICX Revenue
Profile Summary

BioCorRx, Inc., formerly Fresh Start Private Management, Inc., is a holding company. The Company is an addiction healthcare solutions company operating in Santa Ana, California. The Company, through its subsidiary, Fresh Start Private, Inc., provides alcoholism and opioid treatment program. It offers a medication-assisted treatment program that combines non-addictive medication coupled with psycho-social counseling. It also distributes and licenses the BioCorRx Recovery Program for alcoholism and opioid addiction treatment. The BioCorRxO Recovery Program consists of over two parts, which include an implant, administered by a licensed physician, of a compounded formulation of the drug, Naltrexone (implanted under the skin) (the Implant), which reduces alcohol cravings over a period of time, and a structured, intensive one on one counseling program developed by it. It offers BioCorRx Recovery Program in over 10 locations, including California, Arizona, Atlanta, Illinois and others.

Directors
Last Annual December 31st, 2019
Last Interim September 30th, 2020
Incorporated January 28, 2008
Public Since April 16, 2007
No. of Shareholders: 143
No. of Employees: 5
Sector Healthcare
Industry Healthcare Providers & Services
Index
Exchange Pink Sheets on Nasdaq
Shares in Issue 5,421,820
Free Float (0.0%)
Eligible for
ISAs
SIPPs
BICX Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for BICX
Upcoming Events for BICX
Frequently Asked Questions for BioCorRx Inc
What is the BioCorRx Inc share price?

As of 2:30pm, shares in BioCorRx Inc are trading at $2.4, giving the company a market capitalisation of £9.21m. This share price information is delayed by 15 minutes.

How has the BioCorRx Inc share price performed this year?

Shares in BioCorRx Inc are currently trading at $2.4 and the price has moved by -9.71% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the BioCorRx Inc price has moved by -28.08% over the past year.

What are the analyst and broker recommendations for BioCorRx Inc?

There are no analysts currently covering BioCorRx Inc.

When will BioCorRx Inc next release its financial results?

BioCorRx Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-09-30
What is the BioCorRx Inc dividend yield?

BioCorRx Inc does not currently pay a dividend.

Does BioCorRx Inc pay a dividend?

BioCorRx Inc does not currently pay a dividend.

When does BioCorRx Inc next pay dividends?

BioCorRx Inc does not currently pay a dividend.

How do I buy BioCorRx Inc shares?

To buy shares in BioCorRx Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of BioCorRx Inc?

Shares in BioCorRx Inc are currently trading at $2.4, giving the company a market capitalisation of £9.21m.

Where are BioCorRx Inc shares listed? Where are BioCorRx Inc shares listed?

Here are the trading details for BioCorRx Inc:

Country of listing: United States
Exchange: PNK
Ticker Symbol: BICX
What kind of share is BioCorRx Inc?

Based on an overall assessment of its quality, value and momentum, BioCorRx Inc is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a BioCorRx Inc share price forecast 2021?

Shares in BioCorRx Inc are currently priced at $2.4. At that level they are trading at 0.138% discount to the analyst consensus target price of 0.00.

Analysts covering BioCorRx Inc currently have a consensus Earnings Per Share (EPS) forecast of -0.54 for the next financial year.

How can I tell whether the BioCorRx Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like BioCorRx Inc. Over the past six months, the relative strength of its shares against the market has been 19.18%. At the current price of $2.4, shares in BioCorRx Inc are trading at 18.28% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the BioCorRx Inc PE Ratio?

We were not able to find PE ratio data for BioCorRx Inc.

Who are the key directors of BioCorRx Inc?

BioCorRx Inc's management team is headed by:

Lourdes Felix - CEO
Brady Granier - PRE
Kent Emry - DRC
Tomas Welch - EVP
Luisa Ingargiola - IND
Louis Lucido - IND
Joseph Galligan - IND
Who are the major shareholders of BioCorRx Inc?

Here are the top five shareholders of BioCorRx Inc based on the size of their shareholding:

BICX Holding Company, L.L.C. Corporation
Percentage owned: 41.09% (2.23m shares)
Lucido Louis Charles Individual Investor
Percentage owned: 4.83% (262k shares)
Emry (Kent) Individual Investor
Percentage owned: 2.36% (128k shares)
Granier (Brady James) Individual Investor
Percentage owned: 1.7% (92.0k shares)
Felix (Lourdes) Individual Investor
Percentage owned: 0.79% (42.8k shares)
Similar to BICX
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.